NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
EPIKAST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
EPIKAST
ST13
US500000099298653Class
35, 41, 42, 44
Filing
99298653
Registration
8331082
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
07/07/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 41, 42, 44
Filing date
07/23/2025
Registration date
07/07/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2024-05-00
First use in commerce
2024-05-00
Drawing code
4
Owner type
99
Owner location
New York, NY, US
Examiner
CASTRO, GIANCARLO
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Epikast, Inc.
Representatives
Betsy Wang Lee Orrick, Herrington & Sutcliffe LLP
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business organization consulting in the pharmaceuticalbiotechnology and life sciences fields; advertising and marketing in the pharmaceuticalbiotechnology and life sciences fields; analyzing and compiling business data in the pharmaceuticalbiotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; consulting in sales techniques and sales programs; sales volume tracking for othersall in the pharmaceuticalbiotechnology and life sciences fields; promoting the exchange of health information within the medical community to achieve advances in the field of healthcare and promote patient adherence
Class 41
Educational servicesproviding non-downloadable webinars and live workshops in the field of pharmaceutical sales; providing on-line non-downloadable videos in the field of pharmaceutical sales; providing on-line non-downloadable publications in the nature of articles and white papers in the field of pharmaceutical sales; providing podcasts in the field of pharmaceutical sales; training services in the field of pharmaceutical sales; providing on-line newsletters and bulletins in the pharmaceuticalbiotechnology and life sciences fields via email; educational servicesproviding non-downloadable webinars and live workshops in the field of clinical trials; providing on-line non-downloadable videos in the field of clinical trials; providing on-line non-downloadable publications in the nature of articles and white papers in the field of clinical trials; providing on-line non-downloadable videos in the field of clinical trials; providing podcasts in the field of clinical trials
Class 42
Medicalscientific and data analysis research servicesanalyzing clinical trials in the pharmaceuticalbiotechnology and life sciences fields; pharmaceutical drug development and clinical research servicesconsulting services in the area of pharmaceutical clinical testingartificial intelligence (AI) powered data management of clinical trialsbiostatistical analysispreclinical research and development evaluation; providing scientific research information to healthcare professionalspatientsmedicalpharmaceutical and biotechnology companiesusing artificial intelligence (AI) models that provide insights from transcripts and artificial intelligence (AI) models that summarize the latest medical knowledge in a particular field; creating blogs about medical and pharmaceutical information related to chronic illnesses and disease; hosting an online community website for patients and caregivers to communicate about healthcaredesign and development of interactive software for use in the sharing of medical and pharmaceutical information
Class 44
Providing medical information to physicians and health care professionals; providing health information regarding the medications and health care products of othersproduct discontinuationsnew formulationsbottle changesseasonal information through e-mail alerts and push notifications
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2026
PUBO
PUBLISHED FOR OPPOSITION
05/19/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2026
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/21/2026
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
02/24/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/03/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/03/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/03/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/03/2026
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/16/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/16/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/16/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/16/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2025
GNRT
NON-FINAL ACTION E-MAILED
12/15/2025
CNRT
NON-FINAL ACTION WRITTEN
12/15/2025
DOCK
ASSIGNED TO EXAMINER
12/09/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/23/2025
NWAP
NEW APPLICATION ENTERED
07/23/2025
Continuous trademark protection
Get notified about every new filing that threatens EPIKAST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.